New Zealand says new COVID-19 case is 501.V2 variant

A security guard standing outside a COVID-19 clinic near Wellington. AFP/Marty Melville

WELLINGTON - New Zealand's first case of coronavirus in the community for more than two months has been identified as the 501.V2 variant, prompting Australia to suspend quarantine-free travel from the neighbouring country for at least 72 hours.

A 56-year-old woman, who recently returned from Europe, tested positive on Saturday, 10 days after she completed her compulsory two weeks in isolation.

New Zealand has been widely praised for its handling of the pandemic, with just 25 deaths from 1,927 confirmed virus cases in a population of five million.

READ: New Zealand detects first community virus case in two months

The latest case is New Zealand's first in the community since mid-November and has been classified as a strain said to be more transmissible.

"The strain of infection is the South African variant and the source of infection is highly likely to be a fellow returnee," said Hipkins. 

The woman is thought to have been infected during quarantine by a person on the same floor of the hotel who tested positive two days before the woman left. 

WATCH: Karim explains how new variant is highly transmissible

The 56-year-old travelled around the Northland region near Auckland after her release from quarantine and showed symptoms for several days before being tested.

Two people close to her, including her husband, have since returned negative tests and New Zealand's director-general of health Ashley Bloomfield said they likely avoided contracting the illness due to the type of infection.

"She didn't talk about respiratory symptoms, it was more muscle aches, so she may not have been sharing or spreading the virus much," he said.

READ: Kenya says it has detected SA COVID-19 variant

"I don't think that's peculiar to this variant, it's just how it was expressed in this woman."

The World Health Organization has said there is no clear evidence that the 501.V2 variant leads to more severe disease or a higher death rate.

Source
AFP

Paid Content